Encysive Pharmaceuticals Appoints John H. Dillon II to Board of Directors
18 nov. 2004 17h14 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 18, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (NASDAQ:ENCY) today announced the appointment of John H. Dillon II to its Board of Directors. Mr. Dillon's appointment brings the number...
FDA Grants Encysive Orphan Drug Designation For Thelin
11 nov. 2004 07h01 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 11, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (NASDAQ:ENCY) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Thelin(tm)...
Encysive Pharmaceuticals Announces Presentation and Webcast at 5th Annual SG Cowen Global Health Care Conference
09 nov. 2004 16h10 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 9, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that Bruce D. Given, M.D., President and CEO, will give a corporate overview at SG Cowen's 5th Annual...
Encysive Pharmaceuticals to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference
25 oct. 2004 07h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Oct. 25, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that Stephen L. Mueller, Vice President of Finance and Administration, will give a corporate overview at...
Encysive Pharmaceuticals Announces Presentation/Webcast at UBS Global Life Sciences Conference
21 sept. 2004 11h31 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Sept. 21, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that it would participate in the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York...
Encysive Announces Departure of Board Member
02 août 2004 07h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Aug. 2, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that William R. Ringo resigned from the Company's Board of Directors following his appointment as Chief...
Encysive Pharmaceuticals to Present at Adams, Harkness & Hill 24th Annual Summer Seminar
26 juil. 2004 07h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, July 26, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that Bruce D. Given, M.D., President and Chief Executive Officer, will give a corporate overview at the...
Encysive Pharmaceuticals Reiterates Guidance for STRIDE-2 Trial Enrollment
06 juil. 2004 07h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, July 6, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today confirmed that enrollment in the STRIDE-2 clinical trial is expected to complete in the third quarter of 2004....
Encysive Pharmaceuticals Appoints J. Kevin Buchi to Board of Directors
23 juin 2004 07h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, June 23, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that J. Kevin Buchi, 49, has been elected to the Company's Board of Directors and appointed to serve on...
Encysive Pharmaceuticals to Participate in Punk Ziegel Investor Symposium
21 juin 2004 07h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, June 21, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) announced today that Bruce D. Given, M.D., President and Chief Executive Officer, will participate in the Punk Ziegel...